RGNX vs LXRX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
RGNX Captures Institutional Edge (3โ1 Pillars ยท 3โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to REGENXBIO Inc. (RGNX) driven by superior Valuation, Growth & Margin, Options & Structure while LXRX counters with relative strength in Momentum & Technical. Fundamentally, RGNX trades at N/M Forward P/E with -120.4% operating margin (-69.2% YoY revenue) versus LXRX at N/M Forward P/E and -147.4% operating margin (-20.7% YoY). In options structure, RGNX sits in BREAKDOWN (52nd %ile IV; Dealer Gamma Walls on Pro) against LXRX sits in BREAKDOWN (8th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | RGNX Revenue | LXRX Revenue | RGNX Op. Margin | LXRX Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $220M | $30M | 40.3% | -388.5% | RGNX |
| FY2019 | $40M | $30M | -422.9% | 437.5% | LXRX |
| FY2020 | $150M | $20M | -77.1% | -204.2% | RGNX |
| FY2021 | $470M | N/A | 34.0% | N/A | RGNX |
| FY2022 | $110M | N/A | -233.2% | N/A | RGNX |
| FY2023 | $90M | $0M | -297.1% | -15473.0% | RGNX |
| FY2024 | $80M | $10M | -280.0% | -3284.7% | RGNX |
| FY2025 | $170M | $50M | -94.6% | -98.2% | RGNX |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | RGNX | LXRX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $500.9M | $810.3M | Larger Scale | LXRX |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -69.2% | -20.7% | Higher Growth | LXRX |
| Operating Margin (TTM) Profitability | -120.4% | -147.4% | Higher Margin | RGNX |
| Net Profit Margin Profitability | -113.9% | -161.8% | Higher Margin | RGNX |
| Return on Equity (ROE) Capital Efficiency | -113.2% | -43.9% | Higher ROE | LXRX |
| 52-Week Range Position Momentum | 19% ($5โ$16) | 41% ($1โ$3) | Stronger Trend | LXRX |
| Beta / 30D Volatility Risk Regime | 1.81ฮฒ ยท 76% Vol | 0.62ฮฒ ยท 60% Vol | Lower Realized Risk | LXRX |
| Unified Institutional Score Composite Signal | 45.3 / 100 (HOLD) | 38.7 / 100 (SELL) | Higher Composite | RGNX |